Precigen, Inc. (PGEN) stock
PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.29−0.01 (-0.23%)
Close on Nov 17, 2026Market cap $1.54BP/E –Yield –
Precigen price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Precigen's price to sales ratio was 19.7× on Nov 11, 2026, against 20.2× a year earlier. Over the last 5 years it ranged from 3.8× to 152.0×, with a median of 15.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 19.7× | +6.7 |
| 2023 | Oct 31, 2023 | 13.1× | +2.1 |
| 2022 | Dec 30, 2022 | 11.0× | −4.1 |
| 2021 | Dec 31, 2021 | 15.0× | −3.0 |
| 2020 | Dec 31, 2020 | 18.1× | +10.3 |
| 2019 | Dec 31, 2019 | 7.8× | +3.0 |
| 2018 | Dec 31, 2018 | 4.8× | −2.2 |
| 2017 | Dec 29, 2017 | 6.9× | −8.5 |
| 2016 | Dec 30, 2016 | 15.4× | −6.1 |
| 2015 | Dec 31, 2015 | 21.5× | −36.2 |
| 2014 | Dec 31, 2014 | 57.7× | −41.9 |
| 2013 | Dec 31, 2013 | 99.6× | – |
See a number that looks wrong?